Millennium Management’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $179K | Buy |
22,424
+10,534
| +89% | +$84.3K | ﹤0.01% | 3730 |
|
2025
Q1 | $116K | Sell |
11,890
-80,323
| -87% | -$784K | ﹤0.01% | 3732 |
|
2024
Q4 | $1.17M | Sell |
92,213
-27,783
| -23% | -$351K | ﹤0.01% | 2806 |
|
2024
Q3 | $1.93M | Sell |
119,996
-8,012
| -6% | -$129K | ﹤0.01% | 2567 |
|
2024
Q2 | $3.12M | Buy |
128,008
+97,739
| +323% | +$2.38M | ﹤0.01% | 2216 |
|
2024
Q1 | $2.17M | Sell |
30,269
-25,325
| -46% | -$1.82M | ﹤0.01% | 2530 |
|
2023
Q4 | $11.1M | Sell |
55,594
-6,301
| -10% | -$1.25M | ﹤0.01% | 1400 |
|
2023
Q3 | $8.23M | Buy |
61,895
+47,171
| +320% | +$6.27M | ﹤0.01% | 1555 |
|
2023
Q2 | $2.2M | Buy |
14,724
+6,047
| +70% | +$905K | ﹤0.01% | 2459 |
|
2023
Q1 | $1.27M | Buy |
8,677
+1,851
| +27% | +$272K | ﹤0.01% | 2861 |
|
2022
Q4 | $1.08M | Sell |
6,826
-6,215
| -48% | -$984K | ﹤0.01% | 3107 |
|
2022
Q3 | $2.51M | Sell |
13,041
-9,545
| -42% | -$1.84M | ﹤0.01% | 2707 |
|
2022
Q2 | $3.3M | Buy |
22,586
+12,771
| +130% | +$1.86M | ﹤0.01% | 2492 |
|
2022
Q1 | $1.73M | Buy |
9,815
+6,115
| +165% | +$1.08M | ﹤0.01% | 3175 |
|
2021
Q4 | $1.09M | Sell |
3,700
-58,351
| -94% | -$17.1M | ﹤0.01% | 3424 |
|
2021
Q3 | $15.4M | Buy |
62,051
+19,304
| +45% | +$4.79M | 0.01% | 1093 |
|
2021
Q2 | $10.9M | Sell |
42,747
-9,847
| -19% | -$2.5M | 0.01% | 1319 |
|
2021
Q1 | $9.34M | Buy |
52,594
+9,261
| +21% | +$1.64M | 0.01% | 1453 |
|
2020
Q4 | $6.85M | Buy |
43,333
+20,215
| +87% | +$3.19M | ﹤0.01% | 1666 |
|
2020
Q3 | $5.96K | Buy |
23,118
+18,661
| +419% | +$4.81K | 0.01% | 1295 |
|
2020
Q2 | $1.04M | Sell |
4,457
-1,083
| -20% | -$251K | ﹤0.01% | 2374 |
|
2020
Q1 | $943K | Buy |
+5,540
| New | +$943K | ﹤0.01% | 2017 |
|